Analysen von James Gordon
| 25.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 24.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 23.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.10.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 18.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 06.10.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 02.10.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 21.09.17 | GSK Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 14.09.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 11.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 08.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 06.09.17 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 01.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 09.08.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 04.08.17 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 31.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 28.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 25.07.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 24.07.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 21.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 17.07.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 17.07.17 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 13.07.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 13.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 30.06.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.06.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 31.05.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 24.05.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 12.05.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 09.05.17 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 04.05.17 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 25.04.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 20.04.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.04.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 18.04.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 15.03.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 10.03.17 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 09.03.17 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 20.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 15.02.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 13.02.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 09.02.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.02.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 03.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 30.01.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 12.01.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 12.12.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 29.11.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 08.11.16 | MorphoSys Neutral | JP Morgan Chase & Co. | |